Navigation Links
Taiho Pharmaceutical stellt Zulassungsantrag zur Herstellung und Vermarktung des neuartigen Antitumormittels TAS-102
Date:2/26/2013

misierte Doppelblind-Vergleichsstudie von TAS-102 und einem Placebo. Laut Planung werden insgesamt 800 Patienten aus Japan, Nordamerika, Europa und Australien an dieser globalen klinischen Phase-III-Studie teilnehmen. Die Patientenrekrutierung begann im Juni 2012. Die an der Studie teilnehmenden Patienten leiden an inoperablen, rezidivierenden kolorektalen Karzinomen im fortgeschrittenen Stadium und sind für herkömmliche Chemotherapie unempfänglich (Fluoropyrimidin, Irinotecan, Oxaliplatin, Bevacizumab sowie monoklonale EGFR-Antikörper im Falle von KRAS-Wildtyp-Tumoren). Im Zuge der Vergleichsstudie werden Patienten nach dem Zufallsprinzip TAS-102 oder ein Placebo erhalten, um so die Wirksamkeit und Sicherheit von TAS-102 näher zu untersuchen. Das Gesamtüberleben ist der primäre Endpunkt der Studie. Die wissenschaftlichen Leiter sind Dr. Atsushi Otsu , Leiter des klinischen Entwicklungszentrums am National Cancer Center Hospital East (Japan), Dr. Robert J. Mayer des Dana Farber Cancer Institute (USA) und Dr. Eric Van Cutsem vom Universitätskrankenhaus Gasthuisberg (Belgien).

Informationen zu Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical, eine Tochtergesellschaft der Otsuka Holdings Co., Ltd. (http://www.otsuka.com/en/), ist ein auf Forschung und Entwicklung ausgerichtetes, spezialisiertes Pharmaunternehmen, das sich in erster Linie auf die drei Gebiete Onkologie, Allergien und Immunologie sowie Urologie konzentriert. Die Unternehmensphilosophie spiegelt sich in folgendem Versprechen wider: „Wir streben nach einer Verbesserung der menschlichen Gesundheit und wollen zur Bereicherung der Gesellschaft beitragen." Insbesondere im Bereich Onkologie ist Taiho Pharmaceutical in Japan'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
2. Taiho Pharmaceutical présente une demande dhomologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
3. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
4. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
5. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
6. Global Pharmaceutical Industry Trends: Procurement Budgets Stay the Same, Marketing Budgets to Experience Slight Decrease
7. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013
8. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
9. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
10. UBM Launches PharmaEvolution.com, an Online Peer-to-Peer Network for Pharmaceutical Industry Professionals
11. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 05, 2015 Research and Markets ... "Will Theranos Turn the Lab Industry Upside Down?" ... received much praise along with a healthy dose of ... with their potentially disruptive laboratory solution. Behind all of ... Has Theranos scaled microfluidic technology across a comprehensive menu ...
(Date:5/4/2015)... (NASDAQ: LMNX ) today announced financial results for the ... include the following: , Consolidated first quarter revenue ... quarter of 2014. , First quarter assay revenue of ... of 2014. , Consolidated gross profit margin was 70 ... net income for the first quarter was $7.5 million or ...
(Date:5/4/2015)... , May 4, 2015  Neurocrine Biosciences, Inc. (NASDAQ: ... Aurora has joined the company as Vice President, ... to welcome Dr. Bill Aurora to the ... Kevin Gorman , President and Chief Executive Officer ... scientific exchange and outreach coupled with his extensive network ...
Breaking Medicine Technology:Will Theranos Turn the Lab Industry Upside Down? 2Luminex Corporation Reports First Quarter 2015 Results 2Luminex Corporation Reports First Quarter 2015 Results 3Luminex Corporation Reports First Quarter 2015 Results 4Luminex Corporation Reports First Quarter 2015 Results 5Luminex Corporation Reports First Quarter 2015 Results 6Luminex Corporation Reports First Quarter 2015 Results 7Luminex Corporation Reports First Quarter 2015 Results 8Luminex Corporation Reports First Quarter 2015 Results 9Luminex Corporation Reports First Quarter 2015 Results 10Luminex Corporation Reports First Quarter 2015 Results 11Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3
(Date:5/5/2015)... Washington, DC (PRWEB) May 05, 2015 ... Amplify Hope Initiative, a new study aimed at determining ... disease patients. RG is an international non-profit providing rare ... genomics sequencing technology, connections to scientists and researchers, and ... or crowdfunding. , “I am excited to see how ...
(Date:5/5/2015)... 2015 For the growing list of high ... data loggers. This data logger series is based ... for optimum performance throughout exposure to high temperatures and submersion ... are capable of storing up to 32,700 readings and feature ... one year or longer. All data loggers in the HiTemp140 ...
(Date:5/5/2015)... 2015 Sheltering Arms held its annual ... Frazier and Cravath, Swaine & Moore LLP for their ... The event was co-chaired by Vanguard sponsors Morgan Stanley ... Chapter” highlighted Sheltering Arms’ significant growth in New York ... February 2015. Formerly Episcopal Social Services, Sheltering Arms has ...
(Date:5/5/2015)... San Francisco, California (PRWEB) May 05, 2015 ... company based in San Francisco, leads an international initiative ... in order to extend the human lifespan. Scientists ... clocks inherent to women, from the initiation of her ... reveal a possible mechanism for aging and, ultimately, extend ...
(Date:5/5/2015)... ON (PRWEB) May 05, 2015 Crawford Technologies ... Award’ from the Colorado Chapter of the Business ... in 2014. The Gold Key Award was presented to the ... Museum of Nature and Science with over 300 people in ... website in March 2014 represented a shift in focus ...
Breaking Medicine News(10 mins):Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 2Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 3Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 4Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 5Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 6Health News:Sheltering Arms Honors Walt "Clyde" Frazier and Cravath, Swaine & Moore LLP at Annual Gala 2Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:Crawford Technologies Awarded BMA’s ‘2015 Gold Key Award’ for Innovative Website Redesign 2Health News:Crawford Technologies Awarded BMA’s ‘2015 Gold Key Award’ for Innovative Website Redesign 3
... of multiple risk factors at once, , , WEDNESDAY, Feb. ... are already showing signs of some kidney damage may be ... multiple risk factors at once. , That,s the conclusion ... issue of the New England Journal of Medicine , ...
... Foundation has announced the names of the recipients of its ... Dr. Inder Verma is the prize recipient for biomedical science; ... The Vilcek Foundation Prizes are awarded annually to foreign-born ... , In explaining the motivation for the awards, ...
... Preliminary study finds some benefit from calcium channel blockers ... calcium channel blockers to control their high blood pressure ... say long-term use of the drugs also might cut ... the findings are far from definitive and not yet ...
... seek restatement of Beth Israel Deaconess,Medical Center audit, ... the same Sarbanes-Oxley standards used by Staples and other,publicly ... Beth Israel Deaconess,Medical Center (BIDMC), according to labor group ... of Samtex and a director of,Massachusetts-based Virtusa Corporation as ...
... Board of Directors Dashboard, WASHINGTON, Feb. 6 ... (OIG) for the Department of Health,and Human Services (HHS) ... and opportunities for the boards of directors of,long-term care ... of Care Dashboard is a management tool that may ...
... Senetek PLC (OTC,Bulletin Board: SNKTY), a Life ... target the science of healthy aging, today announced,that ... 66th Annual Meeting,of the American Academy of Dermatology ... to the Academy, Dr. Sadick, a prominent New ...
Cached Medicine News:Health News:Aggressive Diabetes Therapy Lowers Death Risk, Study Finds 2Health News:Aggressive Diabetes Therapy Lowers Death Risk, Study Finds 3Health News:Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science 2Health News:Blood Pressure Drugs Might Prevent Parkinson's 2Health News:Blood Pressure Drugs Might Prevent Parkinson's 3Health News:Staples Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:OIG and HCCA Issue Government-Industry Roundtable Report 2Health News:Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology 2
... The Equalizer With 384 Well Plate Capability ... features of the original Equalizerexpandable and equal tip ... and in-lab calibration capabilities. In addition, this model ... to 4.5mm for loading and accessing many gels ...
... description: Quickly transfer samples from ... 64-lane gels. Accurately deliver 0.5-5 ... loaded in six minutes or ... and 377 and other gels ...
... Equally Spaced, Expandable, Multichannel Pipettor ... instantly boosts productivity with an industry breakthroughequal ... adjustment of a slide rod. This innovation ... liquids between vessels with different configurations. ...
... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
Medicine Products: